Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001557746-12-000002
Filing Date
2012-09-10
Accepted
2012-09-10 13:26:46
Documents
1
Effectiveness Date
2012-09-10
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9956
  Complete submission text file 0001557746-12-000002.txt   10994
Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-183855 | Film No.: 121082585